Differences in clinical symptoms, temporal onset, and severity for patients compared with our mouse model may be attributable, at least in part, to the fact that the cardiomyocyte-specific knockout affects both Pkd1 alleles, while ADPKD patients have heterozygous mutations. Here, PKD1 is linked to autosomal dominant polycystic kidney disease.